Skip to content
healthcare.dev

Dalbavancin

NDC 0480-3325, Dalbavancin, injection, powder, for solution, from Teva Pharmaceuticals, Inc..

Product NDC
0480-3325
Status
Listed
Labeler
Teva Pharmaceuticals, Inc.
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219465
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3325 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DALBAVANCIN HYDROCHLORIDE500 mg/25mL

Pharmacologic classes

Lipoglycopeptide Antibacterial [EPC]; Lipoglycopeptides [CS]

Package NDCNDC-11Package
0480-3325-01004803325011 VIAL in 1 CARTON (0480-3325-01) / 25 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1f4a5924-96d7-445a-b75f-2c0e1ffd2dea
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0480-3325

Use it

Look up 0480-3325 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3325 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0480-3325. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.